Ask KHN-PolitiFact: How Can Covid Vaccines Be Safe When They Were Developed So Fast?
Experts say there’s nothing new about the research underpinning the covid vaccines and that they were tested in more participants than many other approved vaccines.
All Coverage
-
-
Covid Vaccine Hesitancy Drops Among All Americans, New Survey Shows
A nationwide poll released by KFF also revealed which arguments are most compelling to persuade people to get a shot — and which ones are unlikely to work.
-
Scientists Seek Covid Treatment Answers in Cheap, Older Drugs
Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.
-
Analysis: How the US Invested in the War on Terrorism at the Cost of Public Health
After 9/11, as our defenses against international and bioterrorism hardened, our defenses against infectious diseases shrank. By the time a deadly virus arrived on our shores last year, nearly two-thirds of Americans were living in counties that spend more than twice as much on policing as they spend on public health.
-
In His Continued Sparring With Fauci, Sen. Rand Paul Oversimplified the Science
The Kentucky lawmaker was right that a recent study offered evidence that vaccination and previous infection appear to neutralize covid-19. But experts say that doesn’t mean people should be complacent.
-
It’s Not Just QAnon. Democrats and Independents Also Want to Recall California’s Governor.
Gov. Gavin Newsom is painting the effort to remove him from office as a partisan power grab. But among the tens of thousands of Californians who signed the recall petition are Democrats and independent voters frustrated by his pandemic policies, from school closures to vaccine distribution.
-
Journalists Dish on Vaccination Loopholes and Alliances
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Military Exposed to Toxic Fumes From Burn Pits Set to Get Bipartisan Boost
Democratic Sen. Kirsten Gillibrand and Republican Sen. Marco Rubio were set to roll out a bill Friday that could help unknown thousands of service members who are sick from toxic substances they were exposed to from burning garbage in Afghanistan, Iraq and other war zones.
-
How One State’s Public Health Defunding Led to Vaccination Chaos
The underfunding of public health and political backlash destabilized Missouri’s vaccine rollout, creating racial inequity and forcing some residents to drive hours to get shots.
-
Democrats Could Undo Trump Policies Faster, But They’re Not. Why?
The little-used Congressional Review Act allows a new administration and Congress to fast-track the repeal of regulations and other executive actions of the previous administration. But neither lawmakers nor the president are making any attempt to use it now.
-
Her Doctor’s Office Moved One Floor Up. Her Bill Was 10 Times Higher.
Same building. Same procedure. Same doctor. But now you’re charged a hospital facility fee. For one Ohio Medicare patient, the copay for a shot that used to cost her about $30 went up to more than $300.
-
‘Incredibly Concerning’ Lawsuit Threatens No-Charge Preventive Care for Millions
A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the law’s popular coverage requirement for preventive services.
-
How Much of Trump’s Health Agenda Has Biden Undone?
In his campaign, President Joe Biden promised to undo policies, particularly health policies, implemented by former President Donald Trump. Yet, despite immense executive power, reversing four years of action takes time and resources.
-
KHN’s ‘What the Health?’: Getting Down to Work at HHS
After a bruising confirmation process, Xavier Becerra was sworn in as secretary of Health and Human Services this week. The Senate also confirmed the nominations of former U.S. Surgeon General Vivek Murthy to return to the post he held in the Obama administration, and former Pennsylvania health secretary Rachel Levine as assistant secretary for health. Levine is the first openly transgender person to receive Senate confirmation. Meanwhile, questions continue to swirl around the AstraZeneca covid vaccine, which some public health experts worry will create more hesitancy toward other vaccines.
-
Nosing In on Kids Who Had Covid and Lost Their Sense of Smell
Clinicians at pediatric hospitals are experimenting with “smell training” among children who had covid-19 and have now lost this sense.
-
Inmates’ Distrust of Prison Health Care Fuels Distrust of Covid Vaccines
Many inmates at Western Missouri Correctional Center, like their peers in prisons across Missouri and the nation, are hesitant about getting vaccinated against covid-19 because they don’t trust prison health care.
-
Stop Blaming Tuskegee, Critics Say. It’s Not an ‘Excuse’ for Current Medical Racism.
The Tuskegee syphilis study is often cited as a reason Black Americans might hesitate to take the covid-19 vaccine. But many people say that current racism in health care and lack of access deserve more attention to move more Black Americans toward vaccine protection.
-
Democrats Gave Americans a Big Boost Buying Health Insurance. It Didn’t Come Cheap.
The $1.9 trillion covid relief bill expands subsidies for private insurance plans. That will lighten the burden on consumers, but it locks taxpayers into yet more support for the health care industry.
-
Lots of Health Insurance Help in Covid Relief Law — But Do Your Homework First
Democrats’ $1.9 trillion covid relief package will offer some of the most significant help for Americans to pay for health insurance in a decade. But the temporary provisions are complicated. KHN offers tips for consumers.
-
Birx Joins Air-Cleaning Industry Amid Land Grab for Billions in Federal Covid Relief
Air-cleaning companies with limited oversight are targeting a growing market of schools desperate for covid-19 protection. Donald Trump’s former covid adviser lands with one that built its business, in part, on ozone-emitting technology.
